CA
TOV

Cambridge Associates’s JLens 500 Jewish Advocacy U.S. ETF TOV Stock Holding History

Cambridge Associates’s Portfolio TOV Stock Details TOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.1M Buy
626,403
+7,462
+1% +$213K 0.27% 36
2025
Q4 		$17.8M Sell
618,941
-456,281
-42% -$13M 0.29% 32
2025
Q3 		$30.2M Buy
1,075,222
+438,545
+69% +$11.8M 0.55% 22
2025
Q2 		$16.6M Buy
+636,677
New +$15.3M 0.37% 27

Other funds holding TOV

NL
NEPC LLC Boston, Massachusetts $5.02B AUM 7.87% 1-Year Est. Return
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SHGA
Sand Hill Global Advisors Palo Alto, California $2.97B AUM 16.57% 1-Year Est. Return
MASUI
MIRAE ASSET SECURITIES (USA) INC. New York $3.58B AUM 45.67% 1-Year Est. Return
SC
Savant Capital Rockford, Illinois $20.7B AUM 19.76% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
TPW
Tiller Private Wealth Bethlehem, Pennsylvania $319M AUM 23.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PWA
Pitcairn Wealth Advisors Conshohocken, Pennsylvania $1.09B AUM

Cambridge Associates's TOV Position: Q1 2026 in Review

Cambridge Associates increased its JLens 500 Jewish Advocacy U.S. ETF (TOV) stake by 1.2% in Q1 2026, buying an estimated $213K and bringing the position to 626,403 shares worth $17.1M. The position accounts for 0.27% of the portfolio, ranked #36.

Cambridge Associates first reported a position in TOV in Q2 2025 and has held it in 4 quarters since. The position peaked at $30.2M in Q3 2025. 22 funds tracked by Wall St. Rank hold TOV as of Q1 2026.

  • Cambridge Associates held 626,403 shares of JLens 500 Jewish Advocacy U.S. ETF worth $17.1M as of Q1 2026.
  • Cambridge Associates bought 7,462 JLens 500 Jewish Advocacy U.S. ETF shares in Q1 2026, an estimated $213K.
  • JLens 500 Jewish Advocacy U.S. ETF made up 0.27% of Cambridge Associates's portfolio in Q1 2026, its #36 holding.
  • Cambridge Associates first reported a position in JLens 500 Jewish Advocacy U.S. ETF in Q2 2025 and has held it in 4 quarters since.
  • Cambridge Associates's JLens 500 Jewish Advocacy U.S. ETF position peaked at $30.2M in Q3 2025.
  • 22 funds tracked by Wall St. Rank held JLens 500 Jewish Advocacy U.S. ETF as of Q1 2026.

Based on Cambridge Associates's 13F filing for Q1 2026, filed 13 May 2026.